Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

NCT00700817

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Huntington Beach, California, United States
View all 166 locations
View Trial Details
Completed

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00614120

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Chongqing, Chongqing Municipality, China
  • Novo Nordisk Investigational Site Fuzhou, Fujian, China
View all 50 locations
View Trial Details
Completed

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

NCT00318461

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Ciudad Autonoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de BsAs, Argentina
  • Novo Nordisk Investigational Site Junín, Argentina
View all 190 locations
View Trial Details
Completed

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

NCT01570751

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Greenbrae, California, United States
  • Novo Nordisk Investigational Site San Ramon, California, United States
View all 46 locations
View Trial Details
Completed

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

NCT01364428

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
View all 45 locations
View Trial Details
Completed

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

NCT01792518

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site North Hollywood, California, United States
  • Boehringer Ingelheim Investigational Site Denver, Colorado, United States
View all 74 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01068678

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Northridge, California, United States
  • Novo Nordisk Investigational Site Palm Springs, California, United States
  • Novo Nordisk Investigational Site Paramount, California, United States
  • Novo Nordisk Investigational Site Santa Ana, California, United States
View all 99 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01076647

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Beverly Hills, California, United States
View all 105 locations
View Trial Details

Related conditions